packageTeriparatide

teriparatide

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Teriparatide, a parathyroid hormone analogue, is used to treat osteoporosis, including postmenopausal osteoporosis, and other bone diseases. It is an approved medicine with several authorised products in the European Union, mainly for osteoporosis.

Summary written by glm-5.3-flash from Wikidata Q411781 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:teriparatide
ATC codes:H05AA02
DrugBank:DB06285
Wikidata:Q411781
molar mass:4118 g/mol (Drugs.Common 25.09, not verified)
logP:-18.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown